Drug, Biomolecule, and Vaccine Delivery

JUNE 9-11, 2025 | AUSTIN, TX
View Co-Located Events

Drug, Biomolecule,
and Vaccine Delivery

Presentations in this session focus on strategies for improving the delivery of traditional small molecule drugs, proteins such as monoclonal antibodies, or genetic material (RNA, DNA). The route of administration can be systemic (e.g., IV, oral) or local (e.g., IM, topical), with the goal of enhancing delivery beyond current approaches. The delivery improvement can be in terms of timing, control, or dosing, but may also address challenges associated with biological responses to the delivery vehicle such as toxicity and immunogenicity.

Submit your Abstract - due April 4

Please first review the information for authors — abstract submission guidelines.

Topics & Application Areas

Sustained/controlled release
Ligand-mediated delivery
Improved accumulation at desired site
Stimulation of specific immune pathways
Avoidance of adverse effects and toxicity
Robust resistance to disease
Other

Symposium Co-Chairs

Helen Zha

Assistant Professor

Rensselaer Polytechnic Institute

Thaisha Wright

Assistant Professor

University of California, Los Angeles

Key Speakers Include

Jorge Almodovar

Associate Professor

University of Maryland, Baltimore County

Zhiqiang Cao

Professor

Wayne State University

Back to Top ↑ Symposium Sessions
	Monday June 9
10:30	Drug, Biomolecule, and Vaccine Delivery
4:00	Drug, Biomolecule, & Vaccine Delivery - Posters

Symposium Program
	Monday June 9

10:30	Drug, Biomolecule, and Vaccine Delivery
	Session chair: Helen Zha, Rensselaer Polytechnic Institute, US; Thaisha Wright, UCLA, US
	Engineering biodegradable microneedle patches to deliver pain medication for farm animals J. Almodovar, University of Maryland Baltimore County, US
	Development of a Novel Oral Formulation of Amphotericin B to Treat Visceral Leishmaniasis (VL) in Vulnerable Populations K. Wasan, C. Leiper, S. Leiper, J. Kim, University of British Columbia, CA
	PEX: Anti-Cancer peptide Family That Specifically Deliver Chemotherapy Into Cancer Cells R. Nechushtai, R. Elber, PD&E Therapeutic Inc, US
	Advancing Protein-Polymer Conjugation for Enhanced Stability and Activity in Drug Delivery Systems T. Wright, University of California, Los Angeles, US
	Zwitterionic Materials for Improved Drug Delivery Z.Q. Cao, Wayne State University, US

4:00	Drug, Biomolecule, & Vaccine Delivery - Posters
	Regulation of cell uptake and intracellular targeting of proteins using homogeneous biodegradable polymeric nanoparticles for targeted therapeutic delivery L. Gildea, A.C.N. Sipowe, V. Tadjuidje, O.A. Forte, V.A. Dennis, Alabama State University, US
	In Silico Investigation of Thalidomide and Derivatives through CRBN Binding Interactions G.L. Ancajas, A.C. Chung, I. Tam, L. Kwak, R.A. Garza-López, Pomona College, US
	Admixing a Chlamydial MOMP Nanovaccine with dmLT Adjuvant Enhances TLR2, Th1 cytokines, and Co-stimulatory Molecules in mouse macrophages A.C. Nguiakam Sipowe, R. Sahu, E.B. Norton, V. Tadjuidje, O. Forte, V.A. Dennis, Alabama State University, US
	Cancer Tumor Diagnosis Using AI from Blood Streams and Rapid Vaccine Development S. Kadulla, HCL America Inc, US
	Revolutionizing Vaccine Development: AI-Powered Automated mRNA Vaccine Design S.N. Faraji, Shiraz University of Medical Sciences, Shiraz, Iran, IR